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Time is a fundamental part of all biological processes. During the whole process of evolution, 
living cells and organisms had to adapt to cyclic variations in the environment. In particular, 
the light and temperature conditions varied with day and night and with the seasons. The 
cellular functions and behavior in organisms were regulated according to their daily needs and 
provision of optimal conditions for survival. 
Time functions in cells are of two kinds. One is the cyclic variation, where the same 
events come back with regular intervals. Thereby, cellular adaptation occurs in a cyclic 
manner. The second way is longitudinal time regulation. From conception on, the 
development of organs occur sequentially and strictly coordinated in time until a mature fetus 
is ready for delivery. The periods of gestation, infant, growth and maturity, as well as aging, 
are strictly regulated in all higher organisms. Total life span is also rather constant within each 
species, although there are differences of many fold between short-lived and long-lived 
species. Thus, all the different longitudinal time periods in the life within a species are strictly 
coordinated to each other and are in concordance with total life span. 
Time regulation in single cells occurs at shorter intervals, both with cyclic and non-
cyclic variations. The oscillations may be down to a few seconds or even parts of seconds, 
such as nerve pulses. Heartbeat in higher organisms usually occurs as a rhythm of about one 
second or less, respiratory rhythm is slower, while the rhythm of the blood pressure is 
according to day and night. As a result, many types of time regulation and adaptation are 
occurring simultaneously in the same organism. Until a few years ago, the study of such time 
keeping was largely confined to the observation of phenomena from the outside and with 
mainly a descriptive approach. This has been replaced by a deeper understanding of the 
underlying biology and regulatory mechanisms at the genetic level (for recent review see 
Koukkari and Sothern, 2006b). 
This thesis deals with the hematopoietic system in mice and in men, a highly adaptable 
tissue with a high cell turnover and many different functions that cover all parts of the body. It 
is therefore no wonder that time keeping is an important part of the regulatory circuits. The 
main emphasis of this thesis is on the elucidation of local clock functions in cells of different 
stage of maturation, and discussion on how the molecular clock in bone marrow (BM) is 
unique compared to other tissues, as well as different between species.  
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Hematopoiesis in general 
During the last 40 years, extensive research has given a complex picture of the hematopoietic 
system. A total of 1.5-2.5 kg of hematopoietic tissue resides in the spongious part of bony 
tissue in the body and functions as a unity. Thus, the red BM has about the size of the liver, or 
more. A magnitude of nearly 10 11 mature neutrophilic granulocytes are mobilized daily from 
the BM to peripheral blood. Turnover time for the whole BM is of a magnitude of two weeks, 
whereby most of the cells in the marrow are replaced at least twice every month. The half-life 
of granulocytes in peripheral blood is only about 7 hours in man, after which they leave the 
blood stream by penetrating the vascular wall and enter into peripheral tissues. Here they 
exert their final functions of phagocytosis and degradation of foreign material for a couple of 
days until they die. This rapid turnover of the cells is totally dependent on a correspondingly 
high rate of cell proliferation in the marrow (reviewed in Benestad and Laerum, 1989). The 
granulocyte numbers in peripheral blood are not constant. They vary within the day and in 
relevance with the physiological state of the organism. Thus, exercise or food administration 
rapidly mobilizes granulocytes into circulation. Pathological conditions induce changes that 
are even more pronounced. For instance, an acute infection can increase the number of 
peripheral blood granulocytes within a few days by a magnitude of up to 10. In addition, the 
BM functions as a reservoir for storing mature cells which can be released according to the 
actual needs. 
Several types of blood cells are formed from specific precursor cells. These originate 
from progenitor cells, which are committed to one of the different cell lines in the marrow: 
granulopoiesis, erythropoiesis, megakaryopoiesis and lymphopoiesis. Progenitor cells are 
immature cells with high proliferative capacity, and most of them are actively cycling, 
producing new progeny. The development of the precursor cells occurs through a stepwise 
maturation, where each cell division is accompanied by a corresponding transcription of the 
genetic program for this particular cell type, ending with mature cells capable of exerting 
specialized functions. At this end stage, most of the mature cells have lost their ability to 
proliferate, such as erythrocytes and granulocytes, as well as megakaryocytes, and to some 
extent also monocytes and lymphocytes. Rapid cell division ends with loss of proliferative 
capacity. Hematopoiesis, therefore, consists of a rapid proliferation within strict limits. 
Progenitor cells are derived from stem cells, which in addition to unlimited cell proliferation 
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are able to produce new cells that can be committed for any of the cell lines in the 
hematopoietic tissue. This will be dealt with in the next section. 
The hematopoietic system develops from the yolk sac. Later, the hematopoietic 
activity in the embryo moves to the liver, while after birth the BM takes over (Keller et al., 
1999). BM stromal tissue has a significant influence on hematopoiesis. Stromal cells are 
important for anchoring of the hematopoietic cells, as well as for their nutrition and regulation 
by providing a microenvironment and producing growth factors and cytokines (Tavassoli and 
Friedenstein, 1983; Wolf, 1999). Stromal cells may support hematopoiesis in vitro, both as 
primary cells and as cell lines (Loeuillet et al., 2001). 
The high plasticity of the hematopoietic system requires a dynamic type of 
organization and multiple interactions (Roeder and Loeffler, 2002). A multitude of regulatory 
factors are involved in both hematopoietic cell production and differentiation including 
cytokines, growth factors, chemokines, polypeptides, and oligopeptides (Rameshwar et al., 
1997; Sachs, 1992; Thomas et al., 2004; Wolf, 1979). Several hormones and other cellular 
factors are involved in the expression of various specific genes and their products (Li et al., 
2003), including the key cell cycle control genes. In addition, the BM has a high density of 
efferent nerves (Calvo and Forteza-Vila, 1969), indicating that the nervous system may also 
be involved. 
Hence, hematopoiesis is a complex process regulated by many different factors. Its 
high proliferative activity combined with plasticity enables rapid adjustment to any alteration 
in the needs of the body. Due to the high ratio of cell production and release, hematopoietic 
tissue is completely dependent on continuous input of newly formed cells from the pool of 
stem cells.  
Properties and functions of stem cells 
By definition, a stem cell is a cell with two main properties: it is capable of an unlimited 
number of divisions, and it can give rise to all cell types within a tissue (Weissman, 2000). 
Usually stem cells are in a resting state with low proliferative activity, but can, when 
activated, have a progeny of more than a million cells within a week. Once a stem cell enters 
differentiation into one or several specific cell types, it has been considered as primarily an 
irreversible process. To what extent this is really so, is at present a matter of debate. Possibly 
some cells with differentiated properties may still be able to exert stem cell functions. 
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There is a hierarchy of three levels in stemness: (1) totipotent stem cells, which can 
give rise to a new individual, including the placenta; (2) pluripotent stem cells, which can 
make at least two different tissues; (3) multipotent stem cells, which can develop into all types 
of cells within a tissue. 
The next level in this hierarchy is a progenitor cell, which is already committed to 
become the ancestor of one cell type. Until a few years ago, “stem cell” was the denomination 
of these two functions, and very little was known about its morphology. With modern 
biological methods, the stem cell surface antigens and other biological properties have been 
characterized. Thereby, they can be specifically sorted out and analyzed morphologically. In 
consequence, this has led to experiments where the progeny of one single stem cell can be 
studied (Krause et al., 2001; Osawa et al., 1996). The development of flow cytometry and 
sorting methods has greatly contributed to the understanding of stem cell functions and other 
characteristics (see below). 
With new methods for studying the clonogenic potential of cells in vitro as well as in 
vivo, the occurrence of tissue-specific stem cells has been studied all over the body. Almost 
an explosion in the numbers of articles on this issue has resulted, and in addition, the 
therapeutic potential of stem cells for reconstituting damaged tissues has been explored 
(Gammaitoni et al., 2003). However, the limited potential for growth and renewal in vitro has 
so far been an obstacle to extensive clinical use. The use of supporting tissues, specific 
growth and chemotactic factors, as well as other factors in the microenvironment transferred 
to in vitro may be promising tools for overcoming this limitation (Moore et al., 1997; Zhong 
et al., 2004). Telomerase activity may be critical for this self-renewal, although the limitations 
of the in vitro environment have so far not been solved (Morrison et al., 1996). 
Although the concept that single immature cells could give rise to all types of 
hematopoietic cells was developed in the 1950s, more systematic attempts of isolating and 
characterizing of stem cells first came with the development of flow cytometry and flow 
sorting starting in the 1970s (van Bekkum et al., 1985; Visser and de Vries, 1994; Weissman, 
2002). Later, it was recognized that both in the unperturbed and irradiated mouse, sequential 
recruitment of stem cells in the marrow was responsible for the maintenance of steady state 
hematopoiesis (Drize et al., 2001). Then, the subclasses of progenitors in BM (e.g., 
responsible for lymphopoiesis) were further characterized (Kondo et al., 1997). 
By use of combinations of different methods, pluripotent stem cells have during the 
last 5-10 years been purified from the brain (Uchida et al., 2000), the skin (Toma et al., 2001), 
the lung (Kim et al., 2005) and some other tissues (Clarke, 2005; Qu-Petersen et al., 2002; Yu 
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et al., 2006). Furthermore, specific neoplastic stem cells with pluripotent properties can be 
isolated from human tumors (Al-Hajj and Clarke, 2004; Collins et al., 2005; Kim et al., 2005; 
Singh et al., 2004). An important part of this scenario is the identification of acute myeloid 
leukemia as a stem cell disease, wherein a subpopulation of the neoplastic cells retain stem 
cell functions (Lecuyer and Hoang, 2004). 
In recent years, particular attention has been paid to the possibility that hematopoietic 
stem cells, being essentially mesodermal in origin, can be harbored by other tissues (Lecuyer 
and Hoang, 2004). Thus, hematopoietic stem cells have been isolated both from brain and 
skeletal muscle (Jackson et al., 1999). Consequently, numerous attempts have been made to 
inject hematopoietic stem cells into other tissues both in the steady state and after injury and 
in the course of regeneration. Hematopoietic stem cells seem to be able to convert to other 
tissues, such as skeletal muscle in cell culture (Abedi et al., 2004), as well as develop in vivo 
into myocytes of skeletal or heart muscle (Muguruma et al., 2003), or hepatocytes (Lagasse et 
al., 2000). However, to what extent this phenomenon can be explained by a real plasticity at 
the single cell level, the cell capability for “re-programming” and/or “transdifferentiation”, or 
it has occurred due to the process of fusion with local differentiated cells, is not yet settled 
(Camargo et al., 2003; Krause, 2002; O'Malley and Scott, 2004; Wagers and Weissman, 
2004). Although more studies have to be done to describe the mechanisms of this 
phenomenon (Wagers and Weissman, 2004), stem cell plasticity in general seems to provide 
an important tool for inducing local repair in damaged tissues of different origins (Poulsom et 
al., 2002). 
 One important reason for the large body of data on hematopoietic stem cells is their 
accessibility from various sources. In contrast to most other tissues in humans, they can easily 
be harvested from peripheral blood, from fetal tissues and umbilical cord blood, as well as by 
sequence sampling of the marrow cavity in the skeleton (Huang et al., 1998). These cells can 
be serially transplanted in immunosuppressed rodents and be easily traced for comparison 
between short term and long term repopulating cells of the perturbed host (Lanzkron et al., 
1999; Spangrude et al., 1995). The cells can also be used for clinical purposes in man. Human 
and rodent stem cells express characteristic surface antigens (Spangrude et al., 1988), in 
particular CD34 (Guo et al., 2003) (although the earliest progenitor cells in a resting state may 
be negative for this marker), c-kit (Kawashima et al., 1996), sca-1 (Spangrude and Scollay, 
1990), but not CD38 (Poznansky et al., 2001) (Figure 1). The combination of these markers 
is successfully used for flow cytometric cell sorting (Spangrude et al., 1988). In addition, stem 
cells have a low number of mitochondria (confirmed by low rhodamine 123 
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 Figure 1.  Lineage negative (Lin-) long- and short-term repopulating hematopoietic stem cells (LT-HSC 
and ST-HSC, respectively) and precursors can be separated by expression of surface markers and 
staining with Hoechst and Rhodomine (Rho). Most primitive HSC in Hoechst-stained bone marrow are 
contained in the side population (SP, see also Figure 2), and are characterized by low Rho fluorescent.  
 
uptake) (Uchida et al., 1996), and they are able to pump out the vital dye Hoechst 33342 
(Hoechst), constituting a so-called side population (SP) cells, enabling their specific flow 
cytometric cell sorting (Goodell et al., 1996) (also see later). 
Extensive attempts have been made to characterize the gene expression pattern 
responsible for “stemness”. Thus, for example, several home box genes have been identified 
as important for the development of primitive hematopoietic stem cells (Akashi et al., 2003; 
Terskikh et al., 2003; Zhou et al., 2001). However, surprisingly, a single gene expression 
studied by quantitative real-time polymerase cell reaction (Q-RT-PCR), as well as different 
types of microarrays, have not yielded a consistent pattern (Lemischka, 2001). Thus, there 
were considerable differences between embryonic and adult stem cells, and also between the 
different sources, including human and mouse stem cells (Lu et al., 2002). Therefore, there 
has been an urgent need for finding a more consistent pattern of key gene expression and not 
only a wide variety of stem cell-related gene expression, which may be more or less global. It 
also remains to be shown to what extent there is a dynamic variation in this gene expression, 
both with time and with the functional state of these cells. 
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Flow cytometry and high-speed cell sorting: application in 
hematopoiesis 
Flow cytometry means quantitative and qualitative measurements of single cells in suspension 
that pass through a light beam with high velocity. The measurements both include the light 
scattering that reflects the size and optical properties of the cells, and the absorption of light 
and emission of fluorescence from cell components that have been stained with a fluorescent 
dye (Shapiro, 2003b). Thereby, multiple cell parameters can be measured simultaneously, and 
by a combination of photodetectors and computer technology, these parameters can be 
analyzed in relation to each other. The flow of cell suspension can be broken up into 
electrically charged droplets after leaving a nozzle and having passed the light source. Cells 
containing specific signals can then be sorted out by passing a static electrical field (Shapiro, 
2003a).  
The first commercial flow cytometers became available in the early 1970s. These were 
both built as analyzers and as cell sorters by use of electrostatic deflection of charged 
droplets. However, a limiting factor was their rate of measuring or sorting, which usually was 
less than 1000 cells (events) per second. Consequently, it took a rather long time to obtain a 
high number of cells, which, for example, could be used for isolating RNA and studying gene 
expression. Especially when sorting out rare subpopulations, in many cases it was impossible 
to obtain a sufficient amount of cells for molecular biological analysis. A great step forward 
was the introduction of commercially available high-speed cell sorters in the early 1990s. By 
combining high pressure and high velocity of cell flow with several coupled photodetectors, 
the rate of sorting and analysis could be increased by a factor of 10-20 (van den Engh, 2000). 
Hence, using modern instruments, it is possible to sort routinely with speeds of 20-30,000 
cells (events) per second (Tsinkalovsky et al., 2005), keeping a high purity of sorted cell 
populations (Figure 2). It should be noted, however, that sorting speed depends on several 
parameters, such as cell source, type, and quality of the sample. Thus, flow sorting has moved 
from being an end-stage analytical tool to the combination of multiparameter analysis and 
based on this, isolating and further processing the cells for other types of methods, including 
cell culture studies. The sorting procedure can be accelerated by using immunomagnetic 
beads as a pre-enrichment step for cell isolation. For instance, these beads can be used for 
removing cells expressing lineage-specific markers, by so-called “lineage negative” (Lin-) 
selection. Another useful combination of these techniques is the application of 










Figure 2. The flow cytometric analysis of cells displayed in region 1 (R1, A) after sorting (B) shows a high 
purity of chosen population. Side population (SP) cells from Hoechst-stained mouse bone marrow were 
isolated in this experiment.  
 
with further analysis of isolated cell fraction purity by flow cytometry. 
Rather early, flow cytometry was used in hematopoiesis as a method of choice for 
analyzing the heterogeneous BM populations (Visser, 1992). Later, it was developed to 
become an everyday tool for studying both normal and pathological marrow (Knapp, 1992; 
Smaaland et al., 1992).  
An extensive survey of different applications of flow cytometry in hematology would 
be outside the scope of this introduction. However, it should be emphasized that flow 
cytometry has served as the main tool for isolation of primitive hematopoietic stem cells 
(Spangrude et al., 1988; Spangrude and Scollay, 1990; Visser, 1992). The employment of 
flow cytometry allows enrichment for quite primitive hematopoietic stem cell subsets using a 
combination of specific surface markers mentioned before (see previous section). Thus, 
sorting of Lin- cells positive for c-kit, sca-1 and Thy-1 low (mice), or CD38- subset of CD34+ 
cells (human) will represent stem cells with long-term reconstituting ability tested in lethally 
irradiated host mice.  
Another flow cytometric approach for hematopoietic stem cells isolation is based on 
the analysis of the functional properties of cells. One of the most useful methods is detection 
of the efflux of the DNA-binding vital dye Hoechst. This method, which was originally 
developed by Goodell et al. (1996) for isolation of mouse BM hematopoietic stem cells, 
yielded a distinct SP that displayed very low blue/red fluorescent emission intensities. This 
property depends on active efflux that is determined by the specific expression of the ATP-
binding cassette transporter G2 (ABCG2) in these particular cells (Zhou et al., 2001). The SP 
was shown to be highly enriched for primitive stem cells with long-term reconstitution ability 
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(Goodell et al., 1996) and was suggested as a marker for quiescent hematopoietic stem cells 
with anti-apoptotic properties (Arai et al., 2004). Additional studies have demonstrated that 
SP cell purification can be used as a general method for enrichment of stem cells from normal 
hematopoietic tissues of mammalian species, including humans (Bhattacharya et al., 2003; 
Goodell et al., 1997). Interestingly, SP cells are also present and exhibit stem cell properties 
in several nonhematopoietic tissues (reviewed in Challen and Little, 2006). Hence, the SP 
phenotype is regarded as a specific marker for stem cells from various sources (Bunting, 
2002; Zhou et al., 2001). SP cells have also been detected in some malignant tissues, where 
they may represent cancer stem cells (Haraguchi et al., 2006; Hirschmann-Jax et al., 2004; 
Kondo et al., 2004; Patrawala et al., 2005).  
In conclusion, flow cytometry (also with the application of immunomagnetic beads) is 
an important tool for isolating and characterizing hematopoietic stem and progenitor cells 
with high purity and specificity. 
Chronobiology in general, circadian variations in hematopoiesis, 
and statistical evaluation of rhythms 
Chronobiology is in the widest sense the knowledge of how the organisms adapts to the 
physical conditions in the environment. Most functions in the body show systematic 24-h 
(circadian) variations (Koukkari and Sothern, 2006b). 
The central pacemaker for circadian and seasonal variations in the body is situated in 
the suprachiasmatic nucleus (SCN), which in the human brain is situated above the chiasmatic 
crossing of the optical nerves and has a diameter of a few millimeters (Bartness et al., 2001). 
The SCN is the principle generator of circadian rhythms and is a part of an entrainment 
system that synchronizes a human being or an animal with its environment. Through complex 
nerve tracts, the SCN is connected to the pineal gland, where melatonin secretion is an 
important effector. In addition, the autonomous nervous system is responsible for peripheral 
tissue connections. Thus, the SCN has been found to be a part of the sympathetic outflow 
from the brain to different organs and tissues in the body, including the adrenal gland, and 
seems to be related to the modulation of neuroendocrine systems connected to the 
hypothalamus (Bartness et al., 2001). The SCN is also involved in the parasympathetic 
nervous system innervations of organs as the thyroid, the liver, the pancreas and the 
submandibular glands.  
Specific photoreceptors in the eye connect the SCN through the optical tract to the 
environment. The ganglion cells of the inner retina contain the pigment melanopsin, which 
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forms dendritic plexuses in a network that allows these cells to capture photostimuli across 
broad spatial domains (Ruby et al., 2002). The surrounding light is an important entrainment 
factor for the adaptation of the body to the environment and connects many important 
functions in the body to environmental cues. Alterations in the light conditions induce 
circadian phase shifting. The length of the day also modulates the light responses and 
mediates important hormonal reactions. Thus, important body functions, such as temperature, 
respiration, blood pressure, and heart beat, vary with day and night and with the succession of 
seasons (Bartness et al., 2001). The same applies to the secretion of many hormones, of which 
each has a characteristic pattern. For example, cortisol varies strongly with the time of the 
day, reaching a maximum in the early morning and a minimum during the night. 
The cell kinetics of different tissues also undergo strong circadian variations, and in 
particular rapidly proliferating tissues such as the BM, the gut mucosa, other surface epithelia 
and the epidermis (Smaaland et al., 1995a). Knowledge about such rhythms has been 
important for the understanding of cytotoxic effects on various tissues, and in particular, side 
effects of cytostatic therapy to normal tissues (Laerum et al., 1995). 
Is has long been known that the different parts of hematopoiesis undergo strong 
circadian and seasonal variations. This applies to the numbers of stem/progenitor cells  and to 
the proliferation of precursor cells of the different cell lines in the marrow sampled from 
human volunteers (Smaaland et al., 2002). In addition, peripheral blood cells undergo similar 
variations, and for example, circulating granulocyte numbers can vary with several orders of 
magnitude that is largely related to variation in serum cortisol (Abrahamsen et al., 1993; 
Laerum, 1995). It is also known that immune functions, including the tendency to allergic 
reactions, undergo considerable circadian variations (Ratajczak et al., 1993; Smaaland et al., 
2002). Both the clonogenicity of human CFU-GM in vitro and the total cell proliferation 
ability in the marrow are varying in parallel with a maximum during the day, roughly 
coinciding with the body temperature rhythm (Smaaland et al., 1992). Even the engraftment 
of stem cells in animal hosts has shown circadian variations, indicating that at least in mice, 
the time of injecting the cells may be critical for the result (D'Hondt et al., 2004). 
Interestingly, after transfer of murine BM progenitor cells to in vitro, the circadian rhythm 
may persist for several days (Bourin et al., 2002). It is therefore a good reason to claim that 
hematopoiesis largely occurs in rhythms, reflecting the renewal of hematopoietic cells as a 
labile pulsating organ (Laerum, 1995). Surprisingly, rhythmic variations could not be found in 
malignant lymphoma cells involving cervical lymph nodes (Smaaland et al., 1995b), 
indicating that malignant growth may be less dependent on environmental cues.  
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The understanding of circadian rhythms in hematopoiesis has been important for 
guiding cancer chemotherapy in order to enable higher doses to be given at time points of low 
proliferative activity. Thereby, toxic side effects due to high doses of cell cycle specific 
cytostatical drugs may be circumvented, giving the opportunity for administering higher doses 
to patients with malignant tumors unrelated to hematopoietic cells (Eriguchi et al., 2003; Levi, 
2006).A critical part of identification of circadian rhythms is the use of an appropriate 
statistical analysis for identification of sequential patterns of variations (Koukkari and 
Sothern, 2006a). In the area of medicine, one of the most commonly used computerized 
methods is the cosinor analysis. Originally introduced by the pioneer Franz Halberg in 1972, 
it has become an important statistical tool for biological studies of rhythms (Koukkari and 
Sothern, 2006a). The cosinor technique involves fitting a curve to a time series of data of a 
predefined period (24 h is often used to approximate the circadian rhythm) by least squares 
linear regression. The main parameters derived from the fitted cosine include (1) a p-value 
from a zero-amplitude test, (2) the double amplitude indicating the predictable range of 
change in the time series from peak to trough of the curve, and (3) the acrophase or peak of 
the fitted curve, in hours and minutes from a defined reference point (e.g., local midnight or 
the previous time of light-onset during light-darkness standardization) (Figure 3). Time series 
are also often analyzed for a time-effect by a one-way analysis of variance (ANOVA).  
Clock genes and their relevance for circadian rhythms 
For several years, it was an open question how the time functions could be regulated in tissues 
and in cells. Over years, researchers had observed that biological time was measured by 
cycles that range from milliseconds to years. Circadian rhythms, which measure time on a 
scale of approximately 24 h, are generated by one of the most ubiquitous and well-studied 
timing systems. Although this was found to be timed by a master clock in the brain that 
coordinated tissue-specific rhythms according to light input from the outside world, very little 
was known about the underlying mechanisms (Reppert and Weaver, 2002).  
A genetic basis for circadian timing was demonstrated about 30 years ago. The existence 
of clock genes was first proven in Drosophila melanogaster, Chlamydomonas reinhardi and 
Neurospora crassa by the isolation of circadian mutants. Later, mutations in clock genes were 
also identified in mammals, such as mouse, hamster and man. The Drosophila period (per) 




Figure 3. Rhythmic characteristics derived from a fitted cosine (created by R.B.Sothern).  
 
known mammalian clock genes have been cloned. A clock gene is usually defined as one 
whose product is required for the generation and/or maintenance of the circadian clock.  
 The cloning of the clock genes had a profound effect on the understanding of time 
regulation in peripheral tissues and led to the identification of clock genes and their protein 
products in different tissues/organs. In particular, the understanding of circadian rhythmicity 
at the intracellular level was significantly improved, thereby giving a clearer picture of 
nuclear and cytoplasmic events related to 24-h oscillations. The general picture is that clock 
genes are ubiquitous in cells including in prokaryotes, in plants, and in lower and higher 
animals. During evolution, such time-keeping functions at the genetic level seemed to occur 
for the first time about 700 million years ago and then have gradually been developing and 
specializing in different species. In a broader sense, all living cells contain internal time 
keeping functions by which they can be in phase with the environment. In mammals, 
circadian oscillations of clock gene expressions have been observed not only in the SCN, but 
also in many peripheral tissues, such as liver, heart, kidney, lung, pancreas, skeletal muscle, 
oral mucosa, skin, BM, and human peripheral blood mononuclear and polymorphonuclear 
cells (Balsalobre et al., 2000; Bjarnason et al., 2001; Boivin et al., 2003; Bourin et al., 2002; 
Chen et al., 2000; Damiola et al., 2000; Muhlbauer et al., 2004; Oishi et al., 1998). 
The question remained to what extent clock functions in peripheral tissues were 
independent or whether they were regulated by the central master clock in the SCN. 
Surprisingly, it has been shown that even in rat fibroblasts cultured in vitro for more than 
three decades,circadian gene expression can still be induced by using a serum shock 
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(Balsalobre et al., 1998). In general, the peripheral clocks seem to be phase-delayed as 
compared to the master clock by a magnitude of about 4 hours (Balsalobre et al., 1998). Thus, 
the model has been proposed that tissues have their own independent clock functions which 
are coordinated by the master clock. If the master clock is severely disturbed or non-
functioning, these may take over as time-regulatory functions. The expression “master and 
slave clocks” therefore has been used for this dependence. 
Traditionally, the clock gene functions and their regulation is described as a complex 
relationship between positive and negative feedback loops of genes and their products 
(reviewed recently by Ko and Takahashi (2006) (Figure 4). In the primary feedback loop, the 
positive elements include members of the basic helix-loop-helix (bHLH)-PAS (Period-Arnt-
Single-minded) transcription factor family, CLOCK and BMAL1. These proteins form 
heterodimers that initiate transcription of target genes containing E-box CIS-regulatory 
enhancer sequences, including Period (in mice, Per1, Per2 and Per3) and cryptochrome 
(Cry1 and Cry2). PER:CRY heterodimers then translocate back to the nucleus and repress 
their own transcription by acting on the CLOCK:BMAL1 complex completing a negative 
feedback loop. Another regulatory loop is induced by CLOCK:BMAL1 heterodimers 
activating transcription of orphan nuclear receptors, Rev-erbα and Rora. REV-ERBΑ and 
RORa regulate the circadian oscillation of Bmal1 subsequently competing for binding orphan 
receptor response elements (ROREs) present in Bmal1 promoter. It has been shown that 
RORs activate transcription of Bmal1, whereas REV-ERBs repress the transcription process. 
The autoregulatory feedback loops take approximately 24 h to complete a cycle and constitute 
a circadian molecular clock. The 24-h molecular clock generation is modified by post-
translational modifications, such as phosphorylation and ubiquitination. These processes 
significantly contribute to the precision of the mammalian clock by affecting the stability and 
nuclear translocation of core clock proteins. Casein kinase 1 epsilon and Casein kinase 1 delta 
(CK1ε and CK1δ) are critical factors that regulate the core circadian protein turnover in 
mammals. Mutations in CK1ε and CK1δ can have dramatic effects on circadian period. 
It should be noted that this traditional concept of circadian clockwork in mammals was 
developed by analogy with the Drosophila system, and evidence in favor of this concept is 
still incomplete (Hastings and Herzog, 2004). Some anomalous observations that run counter 
to the predictions of transcription/translation oscillator model were summarized and discussed 
in a recent review (Lakin-Thomas, 2006). In a recent study it was shown that Clock, one of 
the core clock genes, was not required for rhythmicity (Debruyne et al., 2006). Although 
CLOCK-deficient mice had an altered response to light, they continued expressing robust 
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circadian rhythms. Hence, it is likely that the traditional model of molecular clock 
components interactions can be modified, at least for the mammalian system. 
In mammals, many of the known clock genes have recently been experimentally 
disrupted. The genetic manipulations have resulted in variable phenotypes, whereby a 
disturbance of the circadian rhythmicity is obtained. For example, mPer3-deficient mice 
exhibit about ½ hour shorter periods than control animals. Total arrhythmicity has been 
observed in mBmal1-deficient mice (for review see Balsalobre, 2002). A study of circadian 
rhythmicity in triple mutant mice lacking mPer1, mCry and either mClock or mBmal revealed 
that certain combinations of mPer and mCry are necessary to drive the circadian clockwork. 
The presence of a single gene alone (e.g., mPer1 or mCry1) does not seem to be sufficient to 
induce rhythmic expression of downstream genes, but in this case, light-dark conditions may 
drive the rhythmic oscillator of some output genes (Oster et al., 2003).  
The proteins coded by clock genes and their protein heteromers are transcription 
factors expressed as a circadian cycle. In the widest sense of the word, a clock gene therefore 
denotes a transcription factor responsible for time regulation of other gene(s) as a more or less 
cascade effect (Balsalobre, 2002). These findings are largely based on the studies of neurons 
in the central nervous system and, in particular, the SCN. Thus, the clock genes were shown 
to constitute an important effector function related to input nervous signals induced by light 
effects of the retina. 
The use of systematic gene expression studies has given important information about 
output components of the clock system. Peripheral clocks seem to regulate the temporal 
variations in diverse biological processes by modulating so called “clock-controlled genes”. 
In a comparative analysis of circadian gene expression in mouse liver and heart representing 
12,488 genes, it was found that 8-10% of the genes were expressed rhythmically (Storch et 
al., 2002). It is important to note that only a minor overlap of oscillating genes between 
tissues was found in this study. 
It is probable that most of clock-controlled genes are not directly regulated by clock 
genes, but rather by transcription factors that accumulate or are controlled in a circadian 
manner (Balsalobre, 2002). An interesting example of such a directly regulated gene is Dbp, 
which oscillates in many tissues including the liver. Dbp encodes a transcription factor that 
controls the circadian expression of several digestive enzymes in the liver (Lavery et al., 




Figure 4. Transcription/translation oscillator model of the molecular clockwork. A complex of CLOCK and 
BMAL1 proteins activates transcription of Per1/Per2, Cry1/Cry2, Rev-Erbα and Rorα genes. A complex of 
PERs and CRYs proteins inhibits the positive effects of CLOCK:BMAL1. REV-ERBα and RORα proteins 
modify transcription of Bmal1. Casein kinases (CK) are regulatory factors for PER and CRY proteins. 
CLOCK:BMAL1 can also regulate expression of clock control genes (Ccg).  
From Ko and Takahashi, 2006 (© Published by Oxford University Press). 
 
CLOCK:BMAL1 heterodimers through an E-box (Gachon et al., 2004) (Figure 4). It is 
therefore likely that one common core oscillator in peripheral tissue may regulate many 
tissue-specific clock-controlled genes by directly modulating a relatively small number of 
tissue-specific circadian transcription factors that would then regulate multiple targets 
(Balsalobre, 2002). 
The question can be raised to what extent local clock gene expression can be regulated 
by input signals other than from the central master clock. This also seems to be case. For 
example, it was shown that the DNA-binding activity of CLOCK:BMAL1 heterodimers were 
drastically influenced by the ratio between the amount of reduced and oxidized forms of 
nicotinamide adenine dinucleotide, NAD (Rutter et al., 2002). Since these ratios are affected 
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by cellular metabolism, restricted feeding may thus directly reset peripheral clocks through 
metabolic activity. Temperature and temperature changes effect on circadian clocks was 
shown in cyanobacteria, unicellular algae, plants, fungi, arthropods, and vertebrates (reviewed 
in Rensing and Ruoff, 2002). 
Therefore, clock genes seem to be an integral part of local feedback regulation in 
cellular functions, both by constituting and modifying oscillations according to local and 
central needs.  
Development of chronobiological studies of hematopoiesis at the 
Gade Institute 
An important basis for the present thesis has been more than 25 years of systematic research 
on circadian and circannual variations in hematopoietic tissues. Thus, Nils Petter Aardal 
defended his thesis on circadian patterns in the BM of mice, showing rather labile variations 
of very high magnitude (Aardal, 1983). Olav Sletvold later followed this up by studying how 
this circadian pattern varied with the age of the animal (Sletvold, 1988). Thus the aging 
process in mice was accompanied by both lowered amplitude and alterations of the phasing. 
Robert Sothern in his thesis showed how the application of chronobiology could reduce the 
toxic effect of drugs and chemotherapy, and improve anticancer treatment (Sothern, 1992). 
This was followed by studies on humans by Rune Smaaland. He showed that there were 
strong circadian variations in hematopoietic tissues, based on sequence sampling from male 
volunteers (Smaaland, 1994). In particular, cell cycle distribution varied with the circadian 
period, and as already mentioned, in parallel with clonability of myelopoietic progenitor cells. 
In the work by Smaaland. a statistically significant circadian rhythm was found in cell-cycle 
variations (e.g., DNA S-phase) for Non-Hodgkin’s lymphomas (Smaaland et al., 1995b). 
However, at that time nothing was known about effector functions in the cells, including 
clock genes and timing at the cellular level. This prompted us to pursue a similar study on 
clock gene expression. 
In addition to the studies on the total bone marrow population and their progenitor 
cells, it was of particular interest to know how the precursor cells varied, and if this was in 
accordance with the other circadian rhythmic patterns. This was addressed in a thesis by 
Jenny Foss Abrahamsen, combined with systematic methodological studies of the sampling 
technique (Abrahamsen, 1997).  
Flow cytometric measurements have been an important tool in the studies included in 
all of these theses, combined with other methods. The Gade Institute started work on flow 
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cytometry in 1975 and was the first laboratory in Norway that employed the method on 
clinical material. This included sequence studies on leukemia treatment, as well as the 
development of a new method for quantitative and qualitative studies of phagocytosis (Aardal 
et al., 1979; Bassø, 1983; Bjerknes, 1984). 




PROBLEM FORMULATION AND AIMS OF THE STUDY 
Both hematopoiesis in general and stem/progenitor cells in particular are subjects 
to a multitude of influences. It has been demonstrated that many hematopoietic 
functions in rodents or humans are regulated in a circadian manner. Clock genes 
have been shown to play an important role in different tissues but have only been 
scarcely studied in hematopoiesis. On this background, the following aims of the 
present study were formulated: 
 
1.  To create and standardize the protocol for gene expression analysis in 
hematopoietic cells, including primitive stem cells and following 
preparative high-speed cell sorting (Article I). 
 
2.  To study clock gene expression variations in mouse whole BM population 
and the fraction of primitive stem cells using the advantage of high-speed 
flow cytometric analysis and cell sorting (Article II). 
 
3.  To study clock gene expression variations in human BM stem/progenitor 
cells (Article III). 
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GENERAL DISCUSSION  
Methodological considerations  
Stem/progenitor cell isolation by magnetic beads and flow cytometric sorting 
As the present lack of data on circadian gene expression in hematopoietic stem/progenitor 
cells could partly be explained by methodological difficulties we first aimed at improving and 
standardizing the protocol for gene expression analysis in these cells (Figure 5).  
In the study on mouse BM, we were able to target rare stem cell fractions for analysis, 
as it was possible to collect initially more BM cells by increasing the number of experimental 
animals. For detection of mouse hematopoietic stem cells, we employed a single step Hoechst 
staining method (Goodell et al., 1996). This simple and cheap method has been used 
extensively for purification of mammalian HSCs, and the SP phenotype was clearly shown to 
be a specific marker of primitive stem cells with long-term reconstitution ability (Goodell et 
al., 1996; Goodell et al., 1997). It should be noted, however, that technical issues in cell 
preparation and staining (cell number, dye concentration, duration of staining) and in flow 
cytometric analysis (filter setup, laser alignment) are known to influence SP and could cause 
some discrepancies in data interpretation (Montanaro et al., 2004). In our lab using the basic 
protocol of Goodell et al. (1996) for staining of mouse BM cells, we obtained results very 
similar to others (Article I). In our study, SP cells represented < 0.07% of the cell population, 
and were senstive to ABCG2 transporter inhibition by verapamil, reserpine or a 
fumitremorgin C. Approximately 80% of SP cells also expressed the early hematopoietic 
progenitor antigens sca-1 and c-Kit (Article I). High-speed flow cytometric sorting was 
chosen as a method for SP cell isolation. For the first time we performed a colony-forming 
assay of sorted SP cells (Figure 6) and showed that these cells were more than 75 times 
enriched in clonogenicity as compared to whole BM (Article I). This confirmed that the SP 
isolated in our lab was highly enriched for hematopoietic stem cells.  
As a target cell fraction in the experiments on human BM hematopoietic cells, we chose a 
population of CD34+ stem/progenitor cells. These cells were magnetically separated from 
low-density mononuclear cells using a Direct CD34 Progenitor Cell Isolation Kit and MS+ 
Column (from Miltenyi Biotec, Bergisch Gladbach, Germany). Although a combination of 
markers other than CD34 is reported to represent more primitive stem cell fractions, the 
whole population of CD34+ cells was chosen as a subset used routinely for clinical 
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Figure 5. Methodological approach for combination of flow cytometric, morphological and molecular 
analysis of hematopoietic stem cells. Sorting of cells based on surface marker expression and Hoechst efflux 
revealing side population (SP) allows fast collection of pure cell fractions for further morphological and 
morphological analysis, as well as for in vitro and in vivo studies. By increasing the velocity of the cell flow by a 
magnitude of several fold, automated cytometric cell analysis and sorting can be used for preparative purposes 
and not only as an analytical tool. 
 
applications (Handgretinger et al., 1998). Getting further enrichment in primitive stem cells 
(e.g., isolation of Lin- CD34+CD38- subpopulations, rhodamine low fraction or SP) will also 
considerably reduce cell numbers. In the experiments with sampling of human volunteers, this 
was not technically possible and ethically not advisable. The flow cytometry in this study was 
used for evaluation of isolated cell fraction purity that in these experiments ranged from 70.3 





BFU-E GM-CFU GEMM-CFU 
 
Figure 6. Colony assay of side population (SP) stem cells. The pictures (x 50 magnification) of burst-forming 
units-erythroid (BFU-E, left), granulocyte-macrophage (GM-CFU, middle) and granulocyte, erythroid, 
macrophage, megakaryocyte colony-forming units (GEMM-CFU, right) were taken on day 12 of growth. SP 
cells were plated in a concentration of 100 cells/ml in complete methylcellulose medium (MethoCult 3434, 
StemCell Technologies Inc, Canada). The index colony/cells plated for SP cells was 1/3, and demonstrated more 
than 75 times enrichment in clonogenity compared to the whole bone marrow (Article I). 
 
Hence, the chosen populations of hematopoietic mouse stem cells or human 
stem/progenitor cells, and the methods for cell isolation, were considered appropriate for the 
aims of the study. 
RNA purification  
RNA quality is important for any gene expression analysis. In our studies of simultaneous 
analysis of all major clock genes, RNA quantity was an additional critical factor for the 
evaluation of clock gene interactions. In the beginning, we performed several test experiments 
aimed at finding the best way of preparing cells for further RNA purification. The following 
protocol was chosen as the most appropriate: cells were spun down (300 g, 5 minutes at + 4 
0C), supernatants discarded, pellets snap frozen in liquid nitrogen and placed at –80 0C until 
use. This procedure yielded sufficient quantities of total RNA for further gene expression 
analysis avoiding RNA degradation. Both human and mouse samples were of high quality, 
confirmed by Nano LabChip tests run on an Agilent 2100 Bioanalyzer.  
In the human study, we were able to proceed with the cells within 2-3 hours after BM 
sampling. However, in the mouse study, due to the experimental conditions, Hoechst staining 
and cell sorting were performed after all samples were collected. This raised a question 
whether a delay in cell flow cytometric analysis and sorting could increase the risk of RNA 
degradation. In addition, we needed to prove that (1) flow cytometric sorting itself used in 
experiments with mouse BM, and the long time necessary for collection of appropriate cell 
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numbers, would not influence the RNA quality and (2) clock gene appropriate cell numbers 
would not influence the RNA quality and clock gene expression.  
The results of the study published in Article I indicate that enrichment by high-speed 
flow cytometric cell sorting (even with speeds up to 30,000 events/cells per second) induced 
little or no RNA degradation and did not influence the profile of clock gene expression. Thus, 
we confirmed that the method we used can be employed for circadian variation studies, as 
well as for chronobiological experiments, when collection and preparation of the samples 
cannot be done simultaneously and with a delay span of 12 h or even 24 h. 
Choice of reference genes for evaluation clock gene expression: a “geometric 
mean” approach 
In the studies of circadian clock gene expression when at least some of the target genes are 
expected to vary, it was important to find appropriate reference genes with a constant level of 
expression over 24 h. For both mouse and human studies, we chose the normalization strategy 
described previously (Vandesompele et al., 2002), using the geometric mean of three (mouse 
study) or four (human study) endogenous control genes. Therefore, each sample was 
normalized by dividing the quantity mean of the target gene by the quantity of the geometric 
mean. The quantity for each sample was estimated from the corresponding standard curve. 
This approach allowed us to reduce the possible error related to the use of only one 
housekeeping gene as an endogenous control for normalization.  
Rhythms of main body markers as an indicator of a circadian 
coordination in mice/human during the sampling of BM  
To ensure that experimental animals or human subjects maintained circadian coordination 
during sampling of BM, we tested the levels of so called “body marker rhythms”. High 
amplitude, significant hormonal rhythms were observed in corticosterone and melatonin in the 
mouse study, and in cortisol, growth hormone, testosterone in the human study. In addition, 
core body temperature in the mouse study, and total white blood cells, neutrophils, and 
lymphocytes in the human study also showed significant rhythms. These results indicate that 
the groups of mice and human subjects had a good circadian coordination over the 24 h 
period, when BM was sampled for gene expression analysis.  
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Relative level of clock gene expression (stem/progenitor cells vs. 
whole BM, and mouse vs. human) is dependent on cell population 
and species  
Before our studies, clock genes had never been analyzed in hematopoietic stem cells. 
Therefore, when we found that these genes are expressed in mouse SP cells or human CD34+ 
cells it was important to compare the level of relative expression of key clock genes in these 
cell populations and the whole BM.  
The most pronounced difference in mouse hematopoietic cell populations was found 
for mPer1 expression. In SP stem cells, it was almost 3 times as high as the other clock genes 
at all time-points. Conversely, in the whole BM, mPer1 showed low to moderate expression 
levels when compared to the other clock genes, depending on circadian time (Article II). It 
should be noted here (and will be discussed in the next section) that mPer1 was not rhythmic 
in SP cells, contrary to the whole BM.  
In humans, clock gene relative mRNA expression showed similar levels in CD34+ and 
whole BM cells, with the exception for hBmal1. In both cell types, hPer1, hPer2, hCry1, 
hCry2, hRev-erbα and hClock were expressed at about the same levels within each cell 
population, while hPer1 expression level was several fold lower. Expression of hBmal1 was 
as low as hPer1 in CD34+ cells, while it was the highest of all clock genes in the whole BM 
(Article III).  
Thus, the overall results demonstrated differences in relative levels of clock gene 
expression in hematopoietic cells corresponding to both the studied BM cell populations and 
species. However, we were not able to find any correlation between the level of clock gene 
expression and the rhythmic or non-rhythmic character of its circadian variations (see next 
section) at this time. 
The 24-h variations of clock gene expression are different in mouse 
stem cells and whole BM, which indicates that circadian variations 
of clock genes in mouse BM are developmentally regulated 
With the exception of mPer2, the majority of the key clock genes in mouse hematopoietic SP 
stem cells were not expressed rhythmically over 24-h periods during the constant conditions 
of the study. The pattern of clock gene circadian variations in the stem cells was different 
from that in the whole BM, where circadian rhythms were also observed for mPer1 and 
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mRev-erbα. Even the peaks of mPer2, the only gene which showed 24-h rhythmic expression 
in both cell populations, did not coincide (although acrophases and their 95% limits were not 
significantly different, P=0.145). 
A quite unexpected finding in this study was that circadian variations of mPer1 in 
mouse SP stem cells were weak and/or undeveloped. Per1 is known to be a core circadian 
gene and is regarded as a key marker of the circadian molecular clock. Rhythmic expression 
of this gene has been identified in both central and peripheral tissues. In contrast, we found a 
robust circadian rhythm for mPer1 in the whole BM, where high-amplitude variations of this 
gene were both large and consistent in all three experiments.  
 Recently, Morse et al, 2003 hypothesized that clock gene expression is 
developmentally regulated in testis based on their results that clock genes were constant over 
24 h in this organ. Later, similar pattern of clock gene variations were demonstrated in 
thymus (Alvarez and Sehgal, 2005). These data led authors to a conclusion that the circadian 
clock does not operate in immature cells undergoing differentiation (Alvarez and Sehgal, 
2005). As was discussed earlier, the SP fraction of mouse BM is highly enriched for primitive 
stem cells with long-term reconstitution ability (Goodell et al., 1996), and is comprised 
mostly of quiescent hematopoietic stem cells (Arai et al., 2004). Our findings that circadian 
expression of most of the key clock genes appeared to be non-rhythmic in this cell population 
can indicate that the activity of molecular clocks in mouse hematopoietic stem cells is also 
developmentally regulated. 
Mouse and human hematopoietic BM stem/ progenitor cells have a 
specific profile of circadian clock gene expression that is different 
as compared to other tissues 
In the mouse study we were able to collect liver samples in parallel to BM samples, and thus 
could compare patterns of clock gene expression in hematopoietic cells and liver. This also 
gave the advantage of having liver as a reference tissue, where the circadian patterns of 
molecular clocks are well-documented. In our experiments, 24-h clock gene expression 
variations in liver were similar to that reported by several others, including one in B6D2F1 
mice (Filipski et al., 2004). 
 We found that the circadian organization in the BM was different from liver. Thus, 
mPer1 (only in whole BM), mPer2 and mRev-erbα in hematopoietic cells oscillated with 
amplitudes several-fold lower as compared to liver. In both hematopoietic cell fractions, 
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 Figure 7. mDll1 and mHes1 express circadian rhythms in whole bone marrow (BM, right panel) but not 
significantly in side population (SP) stem cells (left panel, see p values). 
 
circadian expression of mCry1, known to be transcribed rhythmically in liver (Bustin, 2002), 
was more or less constant. Perhaps one of the most interesting findings was that mBmal1 is 
expressed rhythmically and with a high amplitude in liver, but did not oscillate significantly 
in mouse SP stem cells or in whole BM. This result was so unexpected that we repeated the 
analysis of mBmal1 expression in the whole BM using another primer/probe set (Tamaru et 
al., 2003). This reproduced a nonrhythmic mBmal1 expression profile and thus confirmed that 
the absence of mBmal1 rhythmicity in the BM populations was not due to the primers/probe 
design. In addition, we showed that hBmal1 was not significantly rhythmic over 24 h in 
human CD34+ cells.  
Bmal1 is a positive regulator of the molecular clock, and was shown to be expressed 
rhythmically in anti-phase to Per genes in some of the peripheral tissues, such as mouse liver 
(Yamamoto et al., 2004) or human oral mucosa (Bjarnason et al., 2001; Bustin, 2002; 
Yamamoto et al., 2004). Recent studies have demonstrated that the Bmal1 rhythm could also 
be unstable in other tissues, and have an unusual phase relationship with Per2 in human 
peripheral blood mononuclear cells (Teboul et al., 2005), or mouse BM (Granda et al., 2004). 
It was recently suggested that Bmal1 regulation may be tissue-specific (Emery and Reppert, 
2004), since RORs proteins that (with REV-ERB Α) control Bmal1 transcription (Akashi and 
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Takumi, 2005) showed strikingly different patterns across peripheral tissues with varying 
peak times (Guillaumond et al., 2005).  
 Our results that Bmal1 expression was not rhythmic in tested BM populations both in 
mice and humans suggest that it could be undeveloped in rapidly proliferating hematopoietic 
tissues. These data also showed that organization of gene time regulation in BM is different 
from other tissues. This concept is confirmed by our findings that mDbp and mWee1, closely 
related to the clock system in liver, were not rhythmic in mouse BM cells. Both mDbp 
(Lopez-Molina et al., 1997) and mWee1 (Matsuo et al., 2003) displayed a robust circadian 
rhythm in mouse liver and were used as classical examples of clock-controlled genes. 
Interestingly, we found that mDll1, coding a Delta-like ligand for Notch receptor (Karanu et 
al., 2000), and mHes1, a transcription factor and one of the major target of Notch signaling 
(Davis and Turner, 2001), were expressed rhythmically in whole BM (Figure 7, right). Notch 
signaling plays an important role in regulating differentiation and lineage specification in 
hematopoiesis, and the genes related to that system and expressing circadian rhythms could be 
candidate clock-controlled genes in BM. However, additional experiments have to be 
performed (e.g., with clock-gene knockouts) to prove that these genes are directly regulated 
by the clock gene(s). It is of special interest that mDll1 and mHes1 did not oscillate in SP 
stem cells (Figure 7, left) contrary to whole BM. This result confirms that rhythms in 
hematopoietic stem cells are developmentally-regulated. Notable during hematopoiesis, Notch 
signaling is especially important for stem cell compartmentalization, and has the propensity to 
expand the stem cells, promote their self-renewal, and influence their survival (Allman et al., 
2002). Thus, Hes1 plays a significant role in mouse primitive hematopoietic stem cell 
expansion, significantly preserves the long-term reconstituting activity of these cells during 
culture, and induces a several fold increase in mouse SP (Kunisato et al., 2003). This may 
address the question of possible correlations between the regulatory function of Notch 
signaling in stem cells and non-rhythmic expression of at least some of the genes involving in 
this pathway.  
From the point of physiological need, the specific organization of the molecular clock 
in hematopoietic tissue has to be related to its specific functions (see Introduction). Markedly 
different distributions of circadian phases in peripheral tissues (Storch et al., 2002), as well as 
minor overlap of cycling (clock-controlled?) genes between tissues (Panda et al., 2002), 
suggest that the clock system in general is organized in a tissue-specific manner. This 
property of the clock system is physiologically relevant, and useful in the process of 
adaptation of peripheral tissue(s) to particular conditions. This also supports the concept that a 
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molecular clock plays an important role in the regulation of specific tissue functions (Gachon 
et al., 2004).  
Further studies aimed on defining molecular links between circadian clocks and 
gene/protein expression in BM may help to understand how and to what extent hematopoiesis 







1. The developed methodological approach combining flow cytometric 
high-speed sorting (in mice) and magnetic beads isolation (in human) 
of stem/progenitor cell populations with Q-RT-PCR is useful for clock 
gene expression analysis and circadian variation studies in small 
hematopoietic cell fractions 
 
2. We demonstrated, for the first time, clock gene expression in purified 
hematopoietic stem cells in mice and stem/progenitor CD34+ cells in 
human over a 24-h period, with a relative level of expression different 
from that in whole bone marrow. 
 
3. Most clock genes (with the exception of mPer2) studied in mouse 
hematopoietic SP stem cells were not oscillating in a fully organized 
circadian manner, which could indicate that circadian clock gene 
expression variations in mouse bone marrow are developmentally 
regulated. 
 
4. We demonstrated that three of eight key clock genes expressed in 
human bone marrow CD34+ progenitor/stem cells hPer1, hPer2 and 
hCry2 exhibit a significant circadian rhythm.  
 
5. Bmal1 does not oscillate significantly in any of the studied fractions of 
mouse or human hematopoietic cells, which could indicate that Bmal1 
is not rhythmic in hematopoietic tissues.  
 
6. In general, clock gene expression in human and mouse hematopoietic 
bone marrow stem and progenitor cells has a specific circadian profile 
with some differences from the patterns in other tissues. 
 39
REFERENCES 
 Aardal, N.-P. (1983). Hematopoiesis, time and regulatory aspects. University of Bergen. 
Aardal, N. P., Talstad, I. and Laerum, O. D. (1979). Sequential flow cytometric analysis of cellular DNA-
content in peripheral blood during treatment for acute leukaemia. Scand J Haematol 22, 25-32. 
Abedi, M., Greer, D., Colvin, G., Demers, D., Dooner, M., Harpel, J., Weier, H., Lambert, J. and 
Quesenberry, P. (2004). Robust conversion of marrow cells to skeletal muscle with 
formation of marrow-derived muscle cell colonies: a multifactorial process. Exp Hematol 32, 
426-34. 
Abrahamsen, J., Smaaland, R., Sandberg, S., Aakvaag, A. and Lote, K. (1993). Circadian 
variation in serum cortisol and circulating neutrophils are markers for circadian variation of 
bone marrow proliferation in cancer patients. Eur J Haematol 50, 206-12. 
Abrahamsen, J. F. (1997). Methodological circadian studies on human hematopoiesis. University of 
Bergen. 
Akashi, K., He, X., Chen, J., Iwasaki, H., Niu, C., Steenhard, B., Zhang, J., Haug, J. and Li, L. 
(2003). Transcriptional accessibility for genes of multiple tissues and hematopoietic lineages 
is hierarchically controlled during early hematopoiesis. Blood 101, 383-9. 
Akashi, M. and Takumi, T. (2005). The orphan nuclear receptor RORalpha regulates circadian 
transcription of the mammalian core-clock Bmal1. Nat Struct Mol Biol 12, 441-8. 
Al-Hajj, M. and Clarke, M. F. (2004). Self-renewal and solid tumor stem cells. Oncogene 23, 7274-
82. 
Allman, D., Aster, J. C. and Pear, W. S. (2002). Notch signaling in hematopoiesis and early 
lymphocyte development. Immunol Rev 187, 75-86. 
Alvarez, J. D. and Sehgal, A. (2005). The thymus is similar to the testis in its pattern of circadian 
clock gene expression. J Biol Rhythms 20, 111-21. 
Arai, F., Hirao, A., Ohmura, M., Sato, H., Matsuoka, S., Takubo, K., Ito, K., Koh, G. Y. and 
Suda, T. (2004). Tie2/angiopoietin-1 signaling regulates hematopoietic stem cell quiescence 
in the bone marrow niche. Cell 118, 149-61. 
Balsalobre, A. (2002). Clock genes in mammalian peripheral tissues. Cell Tissue Res 309, 193-9. 
Balsalobre, A., Damiola, F. and Schibler, U. (1998). A serum shock induces circadian gene 
expression in mammalian tissue culture cells. Cell 93, 929-937. 
Balsalobre, A., Marcacci, L. and Schibler, U. (2000). Multiple signaling pathways elicit circadian 
gene expression in cultured Rat-1 fibroblasts. Curr Biol 10, 1291-1294. 
Bartness, T. J., Song, C. K. and Demas, G. E. (2001). SCN efferents to peripheral tissues: 
implications for biological rhythms. J Biol Rhythms 16, 196-204. 
Bassø, C. F. (1983). Human peripheral blood phagocyte functions studied by flow cytometry. 
University of Bergen. 
Benestad, H. and Laerum, O. (1989). The Neutrophilic granulocyte. In: Cell Kinetics of the 
inflammatory reaction (ed. O. Iversen), pp. 9-36: Springer Verlag  
Bhattacharya, S., Jackson, J. D., Das, A. V., Thoreson, W. B., Kuszynski, C., James, J., Joshi, S. 
and Ahmad, I. (2003). Direct identification and enrichment of retinal stem cells/progenitors 
by Hoechst Dye Efflux Assay. Invest Ophthalmol Vis Sci 44, 2764-2773. 
Bjarnason, G. A., Jordan, R. C. K., Wood, P. A., Li, Q., Lincoln, D. W., Sothern, R. B., 
Hrushesky, W. J. M. and Ben-David, Y. (2001). Circadian expression of clock genes in 
human oral mucosa and skin: Association with specific cell-cycle phases. Am J Pathol 158, 
1793-1801. 
Bjerknes, R. (1984). Flow cytometric studies of human phagocyte functions. University of Bergen. 
 40
 
 Boivin, D. B., James, F. O., Wu, A., Cho-Park, P. F., Xiong, H. and Sun, Z. S. (2003). 
Circadian clock genes oscillate in human peripheral blood mononuclear cells. Blood 102, 
4143-4145. 
Bourin, P., Ledain, A., Beau, J., Mille, D. and Levi, F. (2002). In-vitro circadian rhythm of murine 
bone marrow progenitor production. Chronobiol Int 19, 57-67. 
Bunting, K. D. (2002). ABC transporters as phenotypic markers and functional regulators of stem 
cells. Stem Cells 20, 11-20. 
Bustin, S. (2002). Quantification of mRNA using real-time reverse transcription PCR (RT-PCR): 
trends and problems. J Mol Endocrinol 29, 23-39. 
Calvo, W. and Forteza-Vila, J. (1969). On the development of bone marrow innervation in new-born 
rats as studied with silver impregnation and electron microscopy. Am J Anat 126, 355-71. 
Camargo, F., Green, R., Capetenaki, Y., Jackson, K. and Goodell, M. (2003). Single 
hematopoietic stem cells generate skeletal muscle through myeloid intermediates. Nat Med 9, 
1520-7. 
Challen, G. A. and Little, M. H. (2006). A side order of stem cells: the SP phenotype. Stem Cells 24, 
3-12. 
Chen, Y.-G., Mantalaris, A., Bourne, P., Keng, P. and Wu, J. H. D. (2000). Expression of mPer1 
and mPer2, Two Mammalian Clock Genes, in Murine Bone Marrow. Biochem Biophys Res 
Commun 276, 724-728. 
Clarke, R. B. (2005). Isolation and characterization of human mammary stem cells. Cell Prolif 38, 
375-86. 
Collins, A. T., Berry, P. A., Hyde, C., Stower, M. J. and Maitland, N. J. (2005). Prospective 
identification of tumorigenic prostate cancer stem cells. Cancer Res 65, 10946-51. 
D'Hondt, L., McAuliffe, C., Damon, J., Reilly, J., Carlson, J., Dooner, M., Colvin, G., Lambert, 
J., Hsieh, C., Habibian, H. et al. (2004). Circadian variations of bone marrow engraftability. 
J Cell Physiol 200, 63-70. 
Damiola, F., Le Minh, N., Preitner, N., Kornmann, B., Fleury-Olela, F. and Schibler, U. (2000). 
Restricted feeding uncouples circadian oscillators in peripheral tissues from the central 
pacemaker in the suprachiasmatic nucleus. Genes Dev 14, 2950-2961. 
Davis, R. L. and Turner, D. L. (2001). Vertebrate hairy and Enhancer of split related proteins: 
transcriptional repressors regulating cellular differentiation and embryonic patterning. 
Oncogene 20, 8342-57. 
Debruyne, J. P., Noton, E., Lambert, C. M., Maywood, E. S., Weaver, D. R. and Reppert, S. M. 
(2006). A clock shock: mouse CLOCK is not required for circadian oscillator function. 
Neuron 50, 465-77. 
Drize, N., Olshanskaya, Y., Gerasimova, L., Manakova, T., Samoylina, N., Todria, T. and 
Chertkov, J. (2001). Lifelong hematopoiesis in both reconstituted and sublethally irradiated 
mice is provided by multiple sequentially recruited stem cells. Exp Hematol 29, 786-94. 
Emery, P. and Reppert, S. M. (2004). A rhythmic Ror. Neuron 43, 443-6. 
Eriguchi, M., Levi, F., Hisa, T., Yanagie, H., Nonaka, Y. and Takeda, Y. (2003). Chronotherapy 
for cancer. Biomed Pharmacother 57 Suppl 1, 92s-95s. 
Filipski, E., Delaunay, F., King, V. M., Wu, M.-W., Claustrat, B., Grechez-Cassiau, A., Guettier, 
C., Hastings, M. H. and Francis, L. (2004). Effects of Chronic Jet Lag on Tumor 
Progression in Mice. Cancer Res 64, 7879-7885. 
Gachon, F., Nagoshi, E., Brown, S. A., Ripperger, J. and Schibler, U. (2004). The mammalian 
circadian timing system: from gene expression to physiology. Chromosoma 113, 103-12. 
Gammaitoni, L., Bruno, S., Sanavio, F., Gunetti, M., Kollet, O., Cavalloni, G., Falda, M., Fagioli, 
F., Lapidot, T., Aglietta, M. et al. (2003). Ex vivo expansion of human adult stem cells 
capable of primary and secondary hemopoietic reconstitution. Exp Hematol 31, 261-70. 
 41
Goodell, M., Brose, K., Paradis, G., Conner, A. and Mulligan, R. (1996). Isolation and functional 
properties of murine hematopoietic stem cells that are replicating in vivo. J Exp Med 183, 
1797-1806. 
Goodell, M. A., Rosenzweig, M., Kim, H., Marks, D. F., DeMaria, M., Paradis, G., Grupp, S. A., 
Sieff, C. A., Mulligan, R. C. and Johnson, R. P. (1997). Dye efflux studies suggest that 
hematopoietic stem cells expressing low or undetectable levels of CD34 antigen exist in 
multiple species. Nat Med 3, 1337-45. 
Granda, T. G., Liu, X.-H., Smaaland, R., Cermakian, N., Filipski, E., Sassone-Corsi, P. and Levi, 
F. (2004). Circadian regulation of cell cycle and apoptosis proteins in mouse bone marrow and 
tumor. FASEB J, 04-2665fje. 
Guillaumond, F., Dardente, H., Giguere, V. and Cermakian, N. (2005). Differential control of 
Bmal1 circadian transcription by REV-ERB and ROR nuclear receptors. J Biol Rhythms 20, 
391-403. 
Guo, Y., Lubbert, M. and Engelhardt, M. (2003). CD34- Hematopoietic Stem Cells: Current 
Concepts and Controversies. Stem Cells 21, 15-20. 
Handgretinger, R., Lang, P., Schumm, M., Taylor, G., Neu, S., Koscielnak, E., Niethammer, D. 
and Klingebiel, T. (1998). Isolation and transplantation of autologous peripheral CD34+ 
progenitor cells highly purified by magnetic-activated cell sorting. Bone Marrow Transplant 
21, 987-93. 
Haraguchi, N., Utsunomiya, T., Inoue, H., Tanaka, F., Mimori, K., Barnard, G. F. and Mori, M. 
(2006). Characterization of a side population of cancer cells from human gastrointestinal 
system. Stem Cells 24, 506-13. 
Hastings, M. H. and Herzog, E. D. (2004). Clock genes, oscillators, and cellular networks in the 
suprachiasmatic nuclei. J Biol Rhythms 19, 400-13. 
Hirschmann-Jax, C., Foster, A. E., Wulf, G. G., Nuchtern, J. G., Jax, T. W., Gobel, U., Goodell, 
M. A. and Brenner, M. K. (2004). A distinct "side population" of cells with high drug efflux 
capacity in human tumor cells. PNAS 101, 14228-14233. 
Huang, S., Law, P., Young, D. and Ho, A. (1998). Candidate hematopoietic stem cells from fetal 
tissues, umbilical cord blood vs. adult bone marrow and mobilized peripheral blood. Exp 
Hematol 26, 1162-71. 
Jackson, K. A., Mi, T. and Goodell, M. A. (1999). From the Cover: Hematopoietic potential of stem 
cells isolated from murine skeletal muscle. PNAS 96, 14482-14486. 
Karanu, F. N., Murdoch, B., Gallacher, L., Wu, D. M., Koremoto, M., Sakano, S. and Bhatia, M. 
(2000). The Notch Ligand Jagged-1 Represents a Novel Growth Factor of Human 
Hematopoietic Stem Cells. J Exp Med 192, 1365-1372. 
Kawashima, I., Zanjani, E., Almaida-Porada, G., Flake, A., Zeng, H. and Ogawa, M. (1996). 
CD34+ human marrow cells that express low levels of Kit protein are enriched for long-term 
marrow-engrafting cells. Blood 87, 4136-4142. 
Keller, G., Lacaud, G. and Robertson, S. (1999). Development of the hematopoietic system in the 
mouse. Exp Hematol 27, 777-87. 
Kim, C. F., Jackson, E. L., Woolfenden, A. E., Lawrence, S., Babar, I., Vogel, S., Crowley, D., 
Bronson, R. T. and Jacks, T. (2005). Identification of bronchioalveolar stem cells in normal 
lung and lung cancer. Cell 121, 823-35. 
Knapp, W. (1992). Antibody-defined surface molecules of normal and malignant hemopoietic cells. 
In: Flow cytometry in hematology, (eds O. D. Laerum and R. Bjerknes), pp. 213-226. London: 
Academic Press. 
Kondo, M., Weissman, I. and Akashi, K. (1997). Identification of clonogenic common lymphoid 
progenitors in mouse bone marrow. Cell 91, 661-72. 
 42
 
Kondo, T., Setoguchi, T. and Taga, T. (2004). Persistence of a small subpopulation of cancer stem-
like cells in the C6 glioma cell line. Proc Natl Acad Sci U S A 101, 781-6. 
Koukkari, W. L. and Sothern, R. B. (2006a). Chronobiometry: analyzing for rhythms. In 
Introducing Biological Rhythms, pp. 577-602. New York: Springer. 
Koukkari, W. L. and Sothern, R. B. (2006b). Clinical Medicine. In Introducing Biological Rhythms, 
pp. 426-525. New York: Springer. 
Krause, D. (2002). Plasticity of marrow-derived stem cells. Gene Ther 9, 754-8. 
Krause, D. S., Theise, N. D., Collector, M. I., Henegariu, O., Hwang, S., Gardner, R., Neutzel, S. 
and Sharkis, S. J. (2001). Multi-organ, multi-lineage engraftment by a single bone marrow-
derived stem cell. Cell 105, 369-77. 
Kunisato, A., Chiba, S., Nakagami-Yamaguchi, E., Kumano, K., Saito, T., Masuda, S., 
Yamaguchi, T., Osawa, M., Kageyama, R., Nakauchi, H. et al. (2003). HES-1 preserves 
purified hematopoietic stem cells ex vivo and accumulates side population cells in vivo. Blood 
101, 1777-83. 
Laerum, O., Smaaland, R. and Abrahamsen, J. (1995). Current concepts for chronochemotherapy 
of cancer. J Infus Chemother 5, 159-70. 
Laerum, O. D. (1995). Hematopoiesis occurs in rhythms. Experimental Hematology 23, 1145-1147. 
Lagasse, E., Connors, H., Al-Dhalimy, M., Reitsma, M., Dohse, M., Osborne, L., Wang, X., 
Finegold, M., Weissman, I. and Grompe, M. (2000). Purified hematopoietic stem cells can 
differentiate into hepatocytes in vivo. Nat Med 6, 1229-34. 
Lakin-Thomas, P. L. (2006). Transcriptional feedback oscillators: maybe, maybe not. J Biol Rhythms 
21, 83-92. 
Lanzkron, S. M., Collector, M. I. and Sharkis, S. J. (1999). Hematopoietic Stem Cell Tracking In 
Vivo: A Comparison of Short-Term and Long-Term Repopulating Cells. Blood 93, 1916-
1921. 
Lavery, D. J., Lopez-Molina, L., Margueron, R., Fleury-Olela, F., Conquet, F., Schibler, U. and 
Bonfils, C. (1999). Circadian expression of the steroid 15 alpha-hydroxylase (Cyp2a4) and 
coumarin 7-hydroxylase (Cyp2a5) genes in mouse liver is regulated by the PAR leucine 
zipper transcription factor DBP. Mol Cell Biol 19, 6488-99. 
Lecuyer, E. and Hoang, T. (2004). SCL: from the origin of hematopoiesis to stem cells and 
leukemia. Exp Hematol 32, 11-24. 
Lemischka, I. (2001). Stem cell dogmas in the genomics era. Rev Clin Exp Hematol 5, 15-25. 
Lévi, F. (2006). Chronotherapeutics: the relevance of timing in cancer therapy. Cancer Causes 
Control 17, 611-21. 
Li, B., Yang, F.-C., Clapp, D. W. and Chun, K. T. (2003). Enforced expression of CUL-4A 
interferes with granulocytic differentiation and exit from the cell cycle. Blood 101, 1769-1776. 
Loeuillet, C., Bernard, G., Remy-Martin, J., Saas, P., Herve, P., Douay, L. and Chalmers, D. 
(2001). Distinct hematopoietic support by two human stromal cell lines. Exp Hematol 29, 736-
45. 
Lopez-Molina, L., Conquet, F., Dubois-Dauphin, M. and Schibler, U. (1997). The DBP gene is 
expressed according to a circadian rhythm in the suprachiasmatic nucleus and influences 
circadian behavior. EMBO J. 16, 6762-6771. 
Lu, S., Li, F., Vida, L. and Honig, G. (2002). Comparative gene expression in hematopoietic 
progenitor cells derived from embryonic stem cells. Exp Hematol 30, 58-66. 
Matsuo, T., Yamaguchi, S., Mitsui, S., Emi, A., Shimoda, F. and Okamura, H. (2003). Control 
mechanism of the circadian clock for timing of cell division in vivo. Science 302, 255-9. 
Montanaro, F., Liadaki, K., Schienda, J., Flint, A., Gussoni, E. and Kunkel, L. M. (2004). 
Demystifying SP cell purification: viability, yield, and phenotype are defined by isolation 
parameters. Exp Cell Res 298, 144-54. 
 43
Moore, K. A., Ema, H. and Lemischka, I. R. (1997). In Vitro Maintenance of Highly Purified, 
Transplantable Hematopoietic Stem Cells. Blood 89, 4337-4347. 
Morrison, S., Prowse, K., Ho, P. and Weissman, I. (1996). Telomerase activity in hematopoietic 
cells is associated with self-renewal potential. Immunity 5, 207-16. 
Morse, D., Cermakian, N., Brancorsini, S., Parvinen, M., and Sassone-Corsi, P. (2003) No 
circadian rhythms in testis: Period1 expression is clock independent and developmentally 
regulated in the mouse. Mol Endocrinol 17, 141-51. 
Muguruma, Y., Reyes, M., Nakamura, Y., Sato, T., Matsuzawa, H., Miyatake, H., Akatsuka, A., 
Itoh, J., Yahata, T., Ando, K. et al. (2003). In vivo and in vitro differentiation of myocytes 
from human bone marrow-derived multipotent progenitor cells. Exp Hematol 31, 1323-30. 
Muhlbauer, E., Wolgast, S., Finckh, U., Peschke, D. and Peschke, E. (2004). Indication of 
circadian oscillations in the rat pancreas. FEBS Letters 564, 91-96. 
O'Malley, K. and Scott, E. (2004). Stem cell fusion confusion. Exp Hematol 32, 131-4. 
Oishi, K., Sakamoto, K., Okada, T., Nagase, T. and Ishida, N. (1998). Humoral signals mediate the 
circadian expression of rat period homologue (rPer2) mRNA in peripheral tissues. Neurosci 
Lett 256, 117-119. 
Osawa, M., Hanada, K., Hamada, H. and Nakauchi, H. (1996). Long-term lymphohematopoietic 
reconstitution by a single CD34-low/negative hematopoietic stem cell. Science 273, 242-5. 
Oster, H., van der Horst, G. and Albrecht, U. (2003). Daily variation of clock output gene 
activation in behaviorally arrhythmic mPer/mCry triple mutant mice. Chronobiol Int 20, 683-
95. 
Panda, S., Antoch, M., Miller, B., Su, A., Schook, A., Straume, M., Schultz, P., Kay, S., 
Takahashi, J. and Hogenesch, J. (2002). Coordinated transcription of key pathways in the 
mouse by the circadian clock. Cell 109, 307-20. 
Patrawala, L., Calhoun, T., Schneider-Broussard, R., Zhou, J., Claypool, K. and Tang, D. G. 
(2005). Side population is enriched in tumorigenic, stem-like cancer cells, whereas ABCG2+ 
and ABCG2- cancer cells are similarly tumorigenic. Cancer Res 65, 6207-19. 
Poulsom, R., Alison, M., Forbes, S. and Wright, N. (2002). Adult stem cell plasticity. J Pathol 197, 
441-56. 
Poznansky, M., Olszak, I., Foxall, R., Piascik, A., Adams, G., Evans, R., Cheng, T. and Scadden, 
D. (2001). Tissue source dictates lineage outcome of human fetal CD34(+)CD38(-) cells. Exp 
Hematol 29, 766-74. 
Qu-Petersen, Z., Deasy, B., Jankowski, R., Ikezawa, M., Cummins, J., Pruchnic, R., Mytinger, 
J., Cao, B., Gates, C., Wernig, A. et al. (2002). Identification of a novel population of 
muscle stem cells in mice: potential for muscle regeneration. J Cell Biol 157, 851-64. 
Rameshwar, P., Poddar, A. and Gascon, P. (1997). Hematopoietic regulation mediated by 
interactions among the neurokinins and cytokines. Leuk Lymphoma 28, 1-10. 
Ratajczak, H., Thomas, P., Sothern, R., Vollmuth, T. and Heck, J. (1993). Evidence for genetic 
basis of seasonal differences in antibody formation between two mouse strains. Chronobiol Int 
10, 383-94. 
Rensing, L. and Ruoff, P. (2002). Temperature effect on entrainment, phase shifting, and amplitude 
of circadian clocks and its molecular bases. Chronobiol Int 19, 807-64. 
Reppert, S. M. and Weaver, D. R. (2002). Coordination of circadian timing in mammals. Nature 
418, 935-941. 
Roeder, I. and Loeffler, M. (2002). A novel dynamic model of hematopoietic stem cell organization 
based on the concept of within-tissue plasticity. Exp Hematol 30, 853-61. 
Ruby, N. F., Brennan, T. J., Xie, X., Cao, V., Franken, P., Heller, H. C. and O'Hara, B. F. (2002). 
Role of melanopsin in circadian responses to light. Science 298, 2211-2213. 
 44
 
Rutter, J., Reick, M. and McKnight, S. L. (2002). Metabolism and the control of circadian rhythms. 
Ann Rev Biochemy 71, 307-331. 
Sachs, L. (1992). The molecular control of hematopoiesis: from clonal development in culture to 
therapy in the clinic. Int J Cell Cloning 10, 196-204. 
Shapiro, H. M. (2003a). How flow cytometers work. In Practical flow cytometry, pp. 101-118: John 
Wiley & Sons. 
Shapiro, H. M. (2003b). Overture. In Practical flow cytometry. pp. 1-60. John Wiley & Sons. 
Singh, S. K., Hawkins, C., Clarke, I. D., Squire, J. A., Bayani, J., Hide, T., Henkelman, R. M., 
Cusimano, M. D. and Dirks, P. B. (2004). Identification of human brain tumour initiating 
cells. Nature 432, 396-401. 
Sletvold, O. (1988). Quantitative aspects of myelopoiesis and blood leukocytes in aging mice. 
University of Bergen. 
Smaaland, R. (1994). Cell proliferation and time-dependent selectivity of cytotoxic treatment of 
malignant tumours. University of Bergen. 
Smaaland, R., Laerum, O. and Abrahamsen, J. (1995a). Circadian cell kinetics in humans. Aspects 
related to cancer chemotherapy. in vivo 9, 529-37. 
Smaaland, R., Laerum, O., Abrahamsen, J., Sothern, R. and Lote, K. (1995b). Cytokinetic 
circadian patterns in human host and tumor. J Infus Chemother 5, 11-4. 
Smaaland, R., Laerum, O., Sothern, R., Sletvold, O., Bjerknes, R. and Lote, K. (1992). Colony-
forming unit-granulocyte-macrophage and DNA synthesis of human bone marrow are 
circadian stage-dependent and show covariation. Blood 79, 2281-2287. 
Smaaland, R., Sothern, R., Laerum, O. and Abrahamsen, J. (2002). Rhythms in human bone 
marrow and blood cells. Chronobiol Int 19, 101-27. 
Sothern, R. B. (1992). Studies on biologically rhythmic natural modifiers of cancer treatment in mice 
and men. Chronotherapeutic concepts and applications. University of Minnesota/University 
of Bergen. 
Spangrude, G. J., Brooks, D. M. and Tumas, D. B. (1995). Long-term repopulation of irradiated 
mice with limiting numbers of purified hematopoietic stem cells: in vivo expansion of stem 
cell phenotype but not function. Blood 85, 1006-16. 
Spangrude, G. J., Heimfeld, S. and Weissman, I. L. (1988). Purification and characterization of 
mouse hematopoietic stem cells. Science 241, 58-62. 
Spangrude, G. J. and Scollay, R. (1990). A simplified method for enrichment of mouse 
hematopoietic stem cells. Exp Hematol 18, 920-6. 
Storch, K., Lipan, O., Leykin, I., Viswanathan, N., Davis, F., Wong, W. and Weitz, C. (2002). 
Extensive and divergent circadian gene expression in liver and heart. Nature 417, 78-83. 
Tamaru, T., Isojima, Y., van der Horst, G. T., Takei, K., Nagai, K. and Takamatsu, K. (2003). 
Nucleocytoplasmic shuttling and phosphorylation of BMAL1 are regulated by circadian clock 
in cultured fibroblasts. Genes Cells 8, 973-83. 
Tavassoli, M. and Friedenstein, A. (1983). Hemopoietic stromal microenvironment. Am J Hematol 
15, 195-203. 
Teboul, M., Barrat-Petit, M. A., Li, X. M., Claustrat, B., Formento, J. L., Delaunay, F., Levi, F. 
and Milano, G. (2005). Atypical patterns of circadian clock gene expression in human 
peripheral blood mononuclear cells. J Mol Med 83, 693-9. 
Terskikh, A. V., Miyamoto, T., Chang, C., Diatchenko, L. and Weissman, I. L. (2003). Gene 
expression analysis of purified hematopoietic stem cells and committed progenitors. Blood 
102, 94-101. 
Thomas, D., Vadas, M. and Lopez, A. (2004). Regulation of haematopoiesis by growth factors - 
emerging insights and therapies. Expert Opin Biol Ther 4, 869-79. 
 45
Toma, J., Akhavan, M., Fernandes, K., Barnabe-Heider, F., Sadikot, A., Kaplan, D. and Miller, 
F. (2001). Isolation of multipotent adult stem cells from the dermis of mammalian skin. Nat 
Cell Biol 3, 778-84. 
Tsinkalovsky, O., Rosenlund, B., Laerum, O. D. and Eiken, H. G. (2005). Clock gene expression 
in purified mouse hematopoietic stem cells. Exp Hematol 33, 100-7. 
Tsinkalovsky, O. R. and Laerum, O. D. (1994). Flow cytometric measurement of the production of 
reactive oxygen intermediate in activated rat mast cells. Apmis 102, 474-80. 
Uchida, N., Buck, D. W., He, D., Reitsma, M. J., Masek, M., Phan, T. V., Tsukamoto, A. S., 
Gage, F. H. and Weissman, I. L. (2000). Direct isolation of human central nervous system 
stem cells. Proc Natl Acad Sci U S A 97, 14720-5. 
Uchida, N., Combs, J., Chen, S., Zanjani, E., Hoffman, R. and Tsukamoto, A. (1996). Primitive 
human hematopoietic cells displaying differential efflux of the rhodamine 123 dye have 
distinct biological activities. Blood 88, 1297-305. 
van Bekkum, D. W., Visser, J. W., Bauman, J. G., Mulder, A. H., Eliason, J. F. and de Leeuw, A. 
M. (1985). Direct morphological and functional examination of murine pluripotent 
hemopoietic stem cells. Ann N Y Acad Sci 459, 143-9. 
van den Engh, G. (2000). High-Speed cell sorting. In Emerging tools for Single-Cell Analysis, (eds 
G. Durack and J. Robinson), pp. 21-48: Wiley-Liss, Inc. 
Vandesompele, J., De Preter, K., Pattyn, F., Poppe, B., Van Roy, N., De Paepe, A. and Speleman, 
F. (2002). Accurate normalization of real-time quantitative RT-PCR data by geometric 
averaging of multiple internal control genes. Genome Biol 3, RESEARCH0034. 
Visser, J. W. and de Vries, P. (1994). Analysis and sorting of hematopoietic stem cells from mouse 
bone marrow. Methods Cell Biol 42 Pt B, 243-61. 
Visser, J. W. M. (1992). Isolation and biological characterization of bone marrow stem cells and 
progenitor cells. In Flow cytometry in hematology, (eds O. D. Laerum and R. Bjerknes), pp. 9-
23. London: Academic Press. 
Wagers, A. J. and Weissman, I. L. (2004). Plasticity of adult stem cells. Cell 116, 639-48. 
Weissman, I. (2002). The road ended up at stem cells. Immunol Rev 185, 159-74. 
Weissman, I. L. (2000). Stem cells: units of development, units of regeneration, and units in 
evolution. Cell 100, 157-68. 
Wolf, N. S. (1979). The haemopoietic microenvironment. Clin Haematol 8, 469-500. 
Wolf, N. S. (1999). The Hematopoietic Microenvironment: Stromal Cell Types: Characterization and 
Function In Situ and In Vitro. Hematol 4, 241-254. 
Yamamoto, T., Nakahata, Y., Soma, H., Akashi, M., Mamine, T. and Takumi, T. (2004). 
Transcriptional oscillation of canonical clock genes in mouse peripheral tissues. BMC Mol 
Biol 5, 18. 
Yu, H., Fang, D., Kumar, S. M., Li, L., Nguyen, T. K., Acs, G., Herlyn, M. and Xu, X. (2006). 
Isolation of a novel population of multipotent adult stem cells from human hair follicles. Am J 
Pathol 168, 1879-88. 
Zhong, R., Law, P., Wong, D., Merzouk, A., Salari, H. and Ball, E. (2004). Small peptide analogs 
to stromal derived factor-1 enhance chemotactic migration of human and mouse 
hematopoietic cells. Exp Hematol 32, 470-5. 
Zhou, G., Chen, J., Lee, S., Clark, T., Rowley, J. D. and Wang, S. M. (2001). The pattern of gene 






The following typographical and grammatical corrections have been made after the 
submission of the thesis. 
Page 17, paragraph 1 after the subtitle, has been added: “…systematic 24-h (circadian) 
variations.” 
Page 19, paragraph 1,  has been added: “…an important statistical tool for biological studies 
of rhythms.” 
Page 19, the last paragraph: “…period (PER) gene…” has been changed to: “…period (per) 
gene…”   
Page 22, the last paragraph: “…accumulate or controlled…” has been changed to: 
“…accumulate or are controlled…” 
Page 27, III, “…(2006) Circadian variations in clock gene expression of human bone marrow 
CD34-positive cells (submitted to J Biol Rhythms).” has been changed to: “…(2007) 
Circadian variations in clock gene expression of human bone marrow CD34-positive cells (J 
Biol Rhythms in press).” 
Page 37, Conclusion 2: “...total bone marrow” has been changed to: “…whole bone marrow.” 
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